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An increase in extremely skewed X-chromosome inactivation (XCI) (90%) among women who experienced
recurrent spontaneous abortion (RSA) has been previously reported. To further delineate the etiology of this
association, we have evaluated XCI status in 207 women who experience RSA. A significant excess of trisomic
losses was observed among the women who had RSA with skewed XCI versus those without skewed XCI (Pp
). There was also a significant excess of boys among live births in this group ( ), which is contrary to.02 Pp .04
expectations if the cause of skewed XCI was only that these women carried X-linked lethal mutations. To confirm
the association between skewed XCI and the risk of trisomy, an independent group of 53 women, ascertained on
the basis of a prenatal diagnosis of trisomy mosaicism, were investigated. Only cases for which the trisomy was
shown to be of maternal meiotic origin were included. The results show a significantly higher level of extreme
skewing (90%) in women whose pregnancies involved placental trisomy mosaicism (17%) than in either of two
separate control populations ( and 99) ( compared with total control subjects). An additional 11np 102 Pp .02
cases were ascertained on the basis of one or more trisomic-pregnancy losses. When all women in the present study
with a trisomic pregnancy ( ) were considered together, skewed XCI was identified in 18%, as comparednp 103
with 7% in all controls ( ) ( ). This difference was more pronounced when a cutoff of extremenp 201 Pp .005
skewing of 95% was used (10% vs. 1.5% skewed; ). Maternal age was not associated with skewing inPp .002
either the patient or control populations and therefore cannot account for the association with trisomy. Previous
studies have shown that a reduced ovarian reserve is associated with increased risk of trisomic pregnancies. We
hypothesize that the association between skewed XCI and trisomic pregnancies is produced by a commonmechanism
that underlies both and that involves a reduction of the size of the follicular pool.
Introduction
Recurrent spontaneous abortion (RSA), defined as loss
of three or more consecutive pregnancies prior to 20 wk
of gestation, is a devastating problem for couples trying
to have children. Despite the extensive medical testing
and experimental treatments that many of these couples
undergo, a cause for their pregnancy loss often remains
unclear (Stephenson 2001). Indeed “chance” may ex-
plain many of these losses, because 15%–20% of all
clinically recognized pregnancies in the general popu-
lation end in spontaneous abortion (SA) (Hassold et al.
Received August 30, 2002; accepted for publication November 11,
2002; electronically published December 20, 2002.
Dr. Wendy Robinson, University of British Columbia, Department
of Medical Genetics, BC Research Institute for Children’s and
Women’s Health, 950 W. 28th Avenue (Room 3086), Vancouver, BC,
Canada V5Z 4H4. E-mail: wprobins@interchange.ubc.ca
 2003 by The American Society of Human Genetics. All rights reserved.
0002-9297/2003/7202-0021$15.00
1996). Nonetheless, the frequency of RSA (1%–2%) is
greater than expected by chance, which suggests that, in
at least some couples, a predisposing factor is present.
Thus, the finding that skewed X-chromosome inacti-
vation (XCI), defined as the preferential inactivation of
one of two X chromosomes in female cells, is increased
in women with RSA (Sangha et al. 1999; Lanasa et al.
2001; Uehara et al. 2001) has led to the exciting prospect
that a cause for these pregnancy losses can be identified
in a subset of women with RSA.
Because there are many potential causes of skewed
XCI (see Brown and Robinson [2000] for a review), the
reason for an association between RSA and skewed
XCI is not clear and may be heterogeneous. Several
authors have suggested that X-linked mutations under-
lie this association (Lanasa et al. 2001; Uehara et al.
2001). This hypothesis proposes that male lethal X-
linked mutations cause skewed XCI in female carriers
and would thus result in an increase in lost male con-
ceptuses and a relative increase in female live births for
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female carriers. X-linked mutations have been clearly
associated with skewed XCI and SA in some families
(Pegoraro et al. 1997), and one study reported a slight
excess of female live births in women with skewed X
CI and RSA (Lanasa et al. 2001). However, without
karyotype information on the SAs to demonstrate an
excess of chromosomally normal males, it is difficult to
determine how often X-linked mutations may explain
these findings.
Alternatively, we have suggested that skewed XCI
may be indicative of an increased risk of trisomy due
to a reduction in size of the pool of embryonic precur-
sors during early development of the affected woman
(Sangha et al. 1999; Robinson et al. 2001a). Any event
that reduces the number of embryonic cells present at
the time of XCI increases the chance of skewed XCI.
For example, a diploid fetus that arises from “trisomic
zygote rescue” is often associated with skewedXCI (Lau
et al. 1997). In this situation, a trisomic conceptus loses
one extra chromosome in early development, producing
a mosaic placenta and/or fetus. Reduced size of the pool
of embryonic precursors may be associated with RSA
by at least two mechanisms: (1) residual trisomic cells
in the oocytes (in females whose own development was
associated with trisomy mosaicism) and (2) poor in
utero growth (of the female when she herself was an
embryo), leading to a reduced total number of primor-
dial ovarian follicles. Since reduced ovarian reserve has
been associated with an increased risk of trisomy (as a
result of an unknown mechanism) (Freeman et al. 2000;
Kline et al. 2000), an excess of trisomic SAs would be
expected if the size of the follicular pool was reduced
in the women with skewed XCI who experience RSA
(Robinson et al. 2001).
To investigate this potential cause of skewed XCI and
RSA, the karyotypes of conceptuses lost by women with
skewed XCI and without skewed XCI were analyzed
and compared. Women with RSA and skewed XCI were
found to have significantly more trisomic losses than
women with RSA without skewed XCI. To further con-
firm that skewed XCI is associated with an increased
risk of trisomy, we then investigated skewed XCI in
mothers who were ascertained only on the basis of hav-
ing a trisomic pregnancy and for whom the trisomy was
confirmed to be of maternal meiotic origin.
Patients, Material, and Methods
Patients
Patients ascertained on the basis of RSA.—Patients
( ) were ascertained through the Recurrent Preg-np 230
nancy Loss Clinic at the British Columbia’s Women’s
Hospital and Health Centre by one of the authors
(M.D.S.), between September 1997 and February 2001.
Each pregnancy was documented by a positive result of
a serum or urine test for human chorionic gonadotropin,
by ultrasound, or by results of a pathologic examination.
Ethics approval was obtained from the University of
British Columbia clinical research ethics board. Periph-
eral blood (7 ml) was obtained after informed consent.
XCI results from 76 of these patients have been reported
elsewhere (Sangha et al. 1999). Women were included
in the study regardless of the outcome of their clinical
evaluation, except for nine women in whom—or in
whose partner—a structural chromosomal abnormality
was found. A total of 207 samples were informative for
our XCI assay (194 for the androgen receptor [AR] locus
and 13 for the fragile-X mental retardation 1 [FMR-1]
locus). The mean age was 34.0 years (range 19–45 years)
at the time blood was sampled in the informativewomen
with RSA. The mean number of live births and SAs in
these patients was 0.9 and 4.4, respectively.
Patients ascertained through trisomy.—Women (np
) were ascertained through prenatal diagnosis of tri-53
somy mosaicism by tests of chorionic villus samples
(CVS) or amniotic fluid (AF), as part of a separate study
on the origin of trisomy mosaicism (Robinson et al.
1997). This group included 1 case each of trisomy 7,
10, 12, and 13; 2 cases each of trisomy 2, 9, 20, and
21; 3 cases of trisomy 14; 36 cases of trisomy 16; and
5 cases of trisomy 22. The trisomy was determined to
be of maternal meiotic origin by molecular analysis, as
reported elsewhere (Robinson et al. 1997; Pen˜aherrera
et al. 2000), except in nine cases of trisomy 16 or 22
mosaicism, in which a maternal meiotic origin was as-
sumed because virtually all cases of trisomy mosaicism
involving these two chromosomes are consequences of
maternal meiotic errors (Robinson et al. 1997). Age was
known for 29 of the 53 patients informative for either
AR ( ), DXS6673E ( ), or FMR-1 ( )np 47 np 4 np 2
XCI assays, and the mean age of the group was 35.6
years (range 25–51 years). However, because all blood
samples were obtained during or shortly after pregnancy,
these were all women of “child-bearing age.”
In our study of trisomy, we also included four women
with a trisomic SA who were ascertained through the
Recurrent Pregnancy Loss Clinic but were not included
in our study of RSA because they did not have three
consecutive losses. Also, after our RSA study, seven
women, from various centers, were ascertained solely on
the basis of having had a trisomic loss. The mean age
of these women was 36.5 years (range 25–42 years). Of
the 11 women, 10 were informative for the AR locus,
and 1 was informative for the DXS6673E locus.
Control Women.—Two control groups were collected.
Control group 1 ( ) consisted of anonymousnp 102
healthy donors ( ) and unaffected spouses fromnp 25
families with Huntington disease ( ). Althoughnp 77
pregnancy history was largely unknown among these
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women, the group should be unbiased in terms of tri-
somic pregnancies or pregnancy losses. In control group
1, exact age was known in 90 women, with a mean age
of 34.6 years (range 17–45 years). All were informative
for the AR ( ) or DXS6673E ( ) XCI assay.np 94 np 8
In those women whose exact age was unknown, the
women were known to be of child-bearing age (i.e.,
20–45 years old). Control group 2 ( ) was col-np 99
lected for comparison with the mothers ascertained for
prenatal diagnosis of trisomy, and it consisted ofmothers
ascertained through various studies of the origin of ge-
netic abnormalities, including mothers of prenatally di-
agnosed mosaic aneuploidy of mitotic origin ( ),np 10
triploidy ( ), and deletions/duplications/translo-np 44
cations ( ). Exact age was known in 87 of 99np 45
control group 2 women who were informative for either
AR ( ) or DXS6673E ( ) XCI assays, withnp 92 np 7
a mean age of 33.0 years (range 21–44 years).
XCI Assay
DNA was extracted from peripheral blood by con-
ventional methods. A DNA methylation-sensitive assay
was used to distinguish the inactive X chromosome from
the active one (Wolf et al. 1984; Yen et al. 1984; Tribioli
et al. 1992). The presence of methylation at a particular
site was determined by digestion with methylation-sen-
sitive restriction enzymes, and the locus was amplified
by PCR, with primers flanking the site of the restric-
tion enzyme cut and a polymorphism. The AR locus
was used, primarily, to assess skewing (Allen et al.
1992). If the AR locus was uninformative, skewing
was assessed at either the FMR-1 (Hecimovic et al.
1997) or DXS6673E (Beever et al., in press) locus. If a
sample was found to have 80% skewing, the assay
was repeated, and an average of the tests was used.
Genomic DNA (300 ng) was digested with 5 U of
HpaII (for the AR and FMR-1 assays)—or 5 U of HhaI
(for the DXS6673E assay)—and 2 U of RsaI in a total
volume of 20 ml. For each sample, an undigested control
was prepared with 300 ng of genomic DNA and 2 U of
RsaI. The digested and undigested samples were incu-
bated at 37C overnight. Complete digestion was as-
sessed by amplification of the 5′ region of theMIC2 gene,
an X-linked gene which escapes XCI and is therefore
always unmethylated at the 5′ end (Goodfellow et al.
1988; Anderson and Brown 2002). This assay was
shown to detect incomplete digestion in a sample with
4.5% incomplete digestion (data not shown).
XCI skewing was estimated with the AR locus, ac-
cording to the protocol of Allen et al. (1992), with the
exception that digested and undigested samples (1.5 ml)
were amplified in 500 nM of each primer (AR PCR1.1
and AR PCR1.2), 2 mM MgCl2, 200 mM each dNTP,
and 0.2 U of Taq (Rose Scientific), in a total volume of
15 ml. PCR conditions were 95C for 5 min (initial de-
naturation); 95C for 45 s, 60C for 30 s, and 72C for
30 s, for 30 cycles, with a final extension at 72C for 7
min. PCR of the FMR-1 locus was performed according
to a modified protocol of Hecimovic et al. (1997), with
primers designed by Fu et al. (1991). Digested and un-
digested samples (1 ml) were amplified in Expand long
PCR buffer 1 (Roche), 10% dimethyl sulfoxide (DMSO),
350 mM dATP, 350 mM dCTP, 350 mM dTTP, 100 mM
dGTP, 250 mM 7-deaza-GTP, 1 mM of each primer, and
0.4 U of Expand enzyme mix (Roche) in a total volume
of 10 ml. Cycling conditions were 97C for 30 seconds
(initial denaturation), followed by 97C for 30 s, 65C
for 45 s, 68C for 4 min with an additional 20 s per
cycle, for 25 cycles. For DXS6673E, digested and un-
digested samples (1 ml) were amplified in a total volume
of 12.5 ml with 200 mM dNTP, 0.5 mM MgCl2, 400 nM
of each primer, and 0.1 U of Rose Taq. Cycling condi-
tions were 95C for 4 min (initial denaturation); 95C
for 1 min, 54C for 1 min, and 72C for 2 min, for 35
cycles, followed by 72C for 7 min (final extension).
Primer sequences were as follows: forward 5′-ATGCTA-
AGGACCATCCAGGA-3′ and reverse 5′-GGAGTTTT-
CCTCCCTCACCA-3′ (Beever et al., in press).
PCR products were visualized, and XCI skewing was
estimated by two methods: (1) densitometry of silver-
stained polyacrylamide gels and (2) automated fluores-
cence analysis. Densitometry of silver-stained polyacryl-
amide gels has been described elsewhere (Lau et al.
1997). For automated fluorescence analysis, PCR was
performed with a forward primer labeled with the ABI
Prism Dyes HEX (for AR and DXS6673E forward
primer) and 6-FAM (for forward FMR-1 primer). The
amplification products were sized using capillary elec-
trophoresis on an ABI Prism 310 genetic analyzer. Fluo-
rescence was detected by ABI Prism data-collection soft-
ware and analyzed by use of GeneScan software. The
peak area for each allele was used to determine XCI
skewing.
Degree of skewing was measured in relation to the
most intense allele (the allele that was inactivated most
often). To account for preferential amplification, the ar-
eas of the peaks of the digested sample were normalized
in relation to measurements from the undigested sample.
The degree of skewing was calculated as (d1/u1)/(d1/
u1d2/u2), where d1 and d2 represent the peak area of
the more intense allele and the less intense allele, re-
spectively, from the digested sample and where u1 and
u2 are the corresponding bands from the undigested
sample. At the AR locus, if alleles of a sample were 3
bp apart, shadow bands of the first allele overlap with
bands of the second allele. In these cases, shadow bands
were calculated to represent ∼30% of the amplification
from one allele, and peak area values were adjusted ac-
cordingly. In the case of RSA samples, skewed XCI was
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Table 1
Skewed XCI in Women with RSA or with a Trisomic Pregnancy
Ascertainment (n)
No. 90%
Skewed XCI (%) P
No. 95%
Skewed XCI (%) P
All RSA (207) 25 (12) .16,a .18,b .08c 11 (5.3) .13,a .06,b .03c
Women with trisomic pregnancy:
RSA (39) 8 (21) .02,a .03,b .007c 5 (13) .02,a .007,b .004d
Non-RSA (11) 1 (9) Not significant 0 (0) Not significant
Non-RSA, Mosaic (53) 9 (17) .05,a,b .02,c 5 (9) .05,a .02,b .01d
Total (103) 18 (18) .005c 10 (10) .002d
Control group:
1 (102) 7 (7) 2 (2)
2 (99) 7 (7) 1 (1)
Total (201) 14 (7) 3 (1.5)
a Compared with control group 1, Fisher’s test.
b Compared with control group 2, Fisher’s test.
c Compared with both control groups, x2 test.
d Compared with both control groups, Fisher’s test.
initially quantified without knowledge of the karyotypes
of conceptuses lost by each woman. Although this is not
true for the women who had trisomic SAs, interpretation
of data from ABI quantification should not be subject
to human bias, because the results are quantified using
the GeneScan software. Furthermore, to ensure accuracy,
all borderline results were repeated several times.
It is important to note that the present protocol differs
from the one used in our previous study (Sangha et al.
1999) in two ways: (1) the MIC2 assay was not previ-
ously used to check for complete digestion and (2) ap-
proximately half of the samples of the present studywere
analyzed with the ABI 310, whereas all samples from
the previous study were analyzed by the silver-staining
method. A number of patient and control samples, par-
ticularly those with alleles of similar size that were re-
ported previously, have been reanalyzed using theMIC2
assay and the ABI 310, and, in some cases, skewing
status changed. Three samples previously showing
skewed XCI with the silver-staining method were no
longer skewed when reanalyzed with the ABI 310,
whereas two samples previously not skewed by silver-
staining changed to skewed when analyzed with the ABI
310. All five of these samples had alleles that differed
in size by only 3 bp, and such close alleles are difficult
to separate and quantify with the silver-staining proto-
col. Analyzing these samples with the ABI 310 allows
for more consistent and accurate quantification of alleles
(authors’ unpublished results). However, samples ana-
lyzed with both the silver-staining method and the ABI
310 show a high correlation in XCI skewing (rp
, ) (data not shown). Thus, samples pre-0.839 np 60
viously analyzed by silver staining were retested on the
ABI only if alleles were close or skewing was 180%.
Statistical Analysis
Fisher’s exact test or x2 analysis was used to compare
the proportion of skewed XCI in patient and control
populations. Given our hypothesis that skewed XCI will
be increased in our patient population, P values from a
one-tailed Fisher’s exact test were reported. Student’s t
test was used to compare the mean age of patient and
control populations and to determine whether age was
a confounding factor in the association of trisomic preg-
nancy and skewed XCI.
Results
Skewed XCI in Women with RSA
Among women with RSA, 25 of 207 (12%) were
found to have extremely skewed XCI (defined, by con-
vention, as90% inactivation of one allele). In contrast,
skewed XCI was observed in 7 of 102 (7%) women in
group 1 and in 7 of 99 (7%) women in control group
2. Thus, women with RSA showed greater XCI skewing
than did control women, although the difference was
not statistically significant ( and , re-Pp .16 Pp .18
spectively, by x2 test when women with RSA were com-
pared with control groups 1 and 2 separately, and
if both control groups are considered together)Pp .08
(table 1). When a more stringent criterion for skewing
(95%) was used, a greater-than-twofold increase in
skewing was seen in women with RSA (5.3%), com-
pared with control group 1 (2.0%) ( , Fisher’sPp .13
exact test), and a fourfold increase was seen compared
with control group 2 (1%) ( , Fisher’s exactPp .058
test). In this case, the difference is statistically significant
if the comparison is made with the sum of both control
groups ( , x2 test). Using a more stringent cutoffPp .03
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Table 2
Karyotypes of Conceptuses Lost by Women with RSA
KARYOTYPE
NO. OF SAS (%) AMONG
Women with
Skewed XCI
(n p 16)
Women without
Skewed XCI
(n p 85)
46,XY 6 (23.1) 43 (29.7)
46,XX 4 (15.4) 40 (27.6)
Trisomy 14 (53.8)a 43 (29.7)
Other abnormalities 2 (7.7) 19 (13.1)
Total 26 145
a , by test, in comparison with all other losses.2Pp .02 x
Table 3
Sex of Live Births to Women with RSA
SEX
NO. OF LIVE BIRTHS TO
Women with 90%
Skewed XCIa
(n p 13)
Women without
Skewed XCI
(n p 113)
Male 15 91
Female 5 79
Total 20 170
a , compared with sex ratio among live births to womenPp .07
without skewed XCI; , compared with an expected male:fe-Pp .04
male ratio of 1:1.
for skewing may be more clinically relevant for the iden-
tification of women in whom RSA is associated with
skewed XCI, because chance may play a smaller role in
the cause of skewed XCI with this cutoff. The mean age
of women with RSA was not significantly different from
that of either control group.
Pregnancy History of Women with RSA and Skewed
XCI
To determine if male lethal X-linked mutations or re-
duced size of the pool of embryonic precursors is sig-
nificantly contributing to pregnancy losses in the women
with skewed XCI and RSA, we examined karyotypes of
losses and sex of live births. No excess of male losses
was seen in the women with90% skewed XCI in com-
parison with those without skewed XCI (table 2). In
addition, an excess of female live births was not seen in
women with skewed XCI (table 3). Unexpectedly, the
opposite trend—an excess of male live births—was
observed.
An increase in trisomic losses was observed in women
with 90% skewed XCI ( , Fisher’s exact test)Pp .02
(table 2). In some cases, more than one karyotyped loss
from the same mother was included in the analysis;
therefore, this test may introduce a bias, because clus-
tering of chromosomally abnormal and normal losses
can occur within family groups. For this reason, we also
analyzed the data in terms of frequency of skewed XCI
in mothers with at least one trisomic loss (21%, np
) versus frequency of skewing in mothers with one or39
more karyotyped losses, none of which was trisomic
(13%, ). Although this difference did not reachnp 63
statistical significance, only the women with a confirmed
trisomic loss showed a significant increase in skewing
compared with controls (7%, ) ( ) (ta-np 201 Pp .007
ble 1). It would be expected that some of the women
with a chromosomally normal loss also had trisomic
losses, since most losses were not karyotyped, thus min-
imizing the difference between these two groups.
The origins of seven trisomic losses from four women
with skewed XCI were determined in a study of recurrent
aneuploidy (Robinson et al. 2001b). Six of these seven
trisomic SAs were found to involve a maternal meiotic
nondisjunction event, whereas one case was due to a
paternal nondisjunction event. The vast majority of spo-
radic trisomic SAs are also due to maternal meiotic er-
rors. In women with trisomic losses, mean maternal age
at the time of loss was slightly lower in women with
skewed XCI than in those without skewed XCI. How-
ever, mean maternal age was increased in all trisomic
losses compared with the mean maternal age for non-
trisomic losses (table 4). Thus, the trisomic losses among
the women with skewed XCI are also associated with
advanced maternal age, as are trisomic losses among the
general population (Hassold et al. 1996). Again, this
analysis is confounded by the inclusion of more than
one loss from the same woman, which may then be
correlated, in terms of maternal age, with one another.
A larger sample size, which then could allow correction
for correlated samples, would be needed to determine
whether, in fact, women with 90% skewed XCI might
be having trisomic SAs at a slightly younger age than
women with !90% skewed XCI.
Skewed XCI in Women with a Trisomic Pregnancy
To verify the association of skewed XCI and trisomy,
we collected samples from 11 additional women who
were ascertained on the basis of a trisomic SA and were
not part of our original study, as well as from 53 women
whowere ascertained on the basis of a prenatal diagnosis
of trisomy mosaicism for which the trisomy was pre-
viously shown to be of maternal meiotic origin (i.e.,
due to a nondisjunction event occurring during oogen-
esis). Skewed XCI (90%) was observed in 18% of all
women with a trisomic SA (including the original RSA
group) ( ) compared with 7% of women in con-np 50
trol group 1 ( ) and 7% of women in controlnp 102
group 2 ( ); both comparisons were significantnp 99
( , Fisher’s exact test). Skewed XCI (90%) wasPp .04
also observed in 17% of women with trisomic preg-
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Table 4
Maternal Age at Time of Pregnancy Loss among Women with RSA
KARYOTYPE
OF LOSS
MEAN AGE (NO. OF SAS) AMONG
Women with 90%
Skewed XCI
(n p 25)
Women without
Skewed XCI
(n p 182)
Trisomic 37.4a (14) 38.2b (42)
Not trisomic 33.6 (12) 33.5 (101)
a .Pp .001
b , one-tailed t test, compared with not trisomic, notP ! .0001
skewed.
Table 5
Maternal Age at Time of Blood Sampling
POPULATION
MEAN AGE (NO.) OF
Women with 90%
Skewed XCI
Women without
Skewed XCI t
Women with RSA 34.2 (25) 34.0 (182) .26
Mothers of trisomy 35.7 (14a) 37.1 (65b) .95
Control women 35.4 (14) 33.7 (164) .92
NOTE.—The skewed and nonskewed groups did not differ in mean
maternal age in any of the three study populations.
a Includes 9 women from the RSA group.
b Includes 41 women from the RSA group.
nancies ( ) compared with 7% of group 1 controlsnp 53
( ) and 7% of group 2 controls ( ) (np 102 np 99 Pp
for both comparisons, Fisher’s exact test) (table 1)..05
When a higher skewing cutoff (95%) was used, a four-
fold and an eightfold increase, respectively, of skewed
XCI was observed in mothers of mosaic trisomy (8%)
compared with group 1 controls (2%) and group 2 con-
trols (1%) ( and , respectively, Fisher’sPp .09 Pp .05
exact test). When all women with trisomic pregnancies
were grouped together and compared with control
groups 1 and 2 combined, the association of skewed
XCI and trisomy was found to be highly significant
( , Fisher’s exact test) (table 1).Pp .005
The mean age of all the mothers who had a trisomic
SAwas increased over control group 1 and control group
2 ( and , respectively, one-tailed tPp .003 P ! .0001
test). The mean age of the mothers of mosaic trisomy
was increased over control group 2 ( , one-tailedPp .02
t test) but not over control group 1 ( , one-tailedPp .25
t test). Because skewed XCI has been reported to increase
with very high maternal ages (165 years) (Sharp et al.
2000), it was important to verify whether this could be
a confounding factor in our study. However, there was
no evidence for any correlation between skewing and
maternal age in the total group of women who a had
trisomic SA ( ; 95% CIp 22 to .22), nor wasrp .002
the correlation significant in the total control population
( ; 95% CIp .03 to .26). Furthermore, thererp .12
was no increase in maternal age when we compared the
90% skewing group with the !90% skewing group in
either of our patient populations, nor in our control
populations (table 5). In fact, the mean maternal age
among women who had a trisomic pregnancy with
90% skewing was actually slightly lower than the
mean age among those with !90% skewing. Of further
note, the mean maternal age of 34.6 years among eight
mothers who had trisomic pregnancy and 195% skew-
ing and who were informative for maternal age was even
lower than that for 90% skewing.
Association of Skewed XCI with Type of Trisomy
The association with maternal age varies by type of
trisomy (Hassold et al. 1996). Specifically, trisomy 16
increases linearly with maternal age, whereas most other
trisomies increase exponentially with maternal age. We
therefore examined skewed XCI separately, depending
on whether the mother was ascertained on the basis of
a trisomy 16 pregnancy. Interestingly, among the 33
cases ascertained through prenatal diagnosis of mosaic
trisomy 16, only 2 women exhibited skewed XCI (6%),
whereas, among the 20 women ascertained on the basis
of other (non-16) mosaic trisomies, skewed XCI was
found in 7 cases (35%). The frequency of skewing was
thus more pronounced when trisomy 16 was excluded
from the analysis, and the difference between these two
subgroups was statistically significant ( , Fisher’sPp .04
exact test). A similar trend was not noted among the
women who had RSA that included one SA with trisomy
16; 4 of these 18 women (22%) showed skewed XCI.
However, it is important to note that all of the cases in
this group had other miscarriages and that most were
confirmed to have other trisomic losses not involving
trisomy 16.
Discussion
In the present study, we report an increase in skewed
XCI among women who experience RSA, although this
difference is no longer as striking as the one in our earlier
report (Sangha et al. 1999). The difference may be ex-
plained by changes in our methodology for estimating
skewing, as well as by the addition of new case and
control subjects. Nonetheless, because all studies re-
ported to date (Kristiansen et al. 1999; Lanasa et al.
1999; Uehara et al. 2001; Sullivan et al. 2002) have
shown an increase of skewed XCI in women who ex-
perience RSA, it appears likely that this effect is real,
even if not statistically significant in all studies. Fur-
thermore, the difference was greater when the more
stringent cutoff of 95% skewing was used. The greater
number of trisomic losses among women who had RSA
with skewed XCI than among women who had RSA
without skewed XCI is further evidence of a clinical dif-
ference between these two groups. We subsequently ver-
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ified the association between skewed XCI and risk of a
trisomic conception in a separate population of women
who were ascertained because of a trisomic pregnancy
that resulted from a maternal meiotic error. These
women were also found to have an increase in skewed
XCI compared with both the normal control women and
with a control group of women who had experienced a
chromosomally abnormal pregnancy that was not due
to an error of segregation at maternal meiosis. Although
it would have been preferable to ascertain control sub-
jects among women known to have no history of a tri-
somic pregnancy, there is no reason to think the control
individuals should be biased in any way regarding XCI
inactivation status. When all mothers of a trisomy are
evaluated together, the increase in skewed XCI is highly
significant ( ) (table 1). Thus, skewed XCI ap-Pp .005
pears to be more strongly associated with a trisomic
pregnancy than with RSA in general.
Little is known about the etiology of trisomy, except
that maternal age is a strong contributing factor and
that most errors leading to trisomy occur during ma-
ternal meiosis (Hassold and Hunt 2001). The present
results provide additional evidence that certain women
(e.g., those with skewed XCI) may be at increased risk
of trisomy. Although some early epidemiological studies
did not show evidence of increased recurrence risk after
a trisomic SA when compared with control women
(Warburton et al. 1987), age is such a strong risk factor
for trisomy that the roles of other factors have been
difficult to measure using an epidemiological approach
(Morton et al. 1987). Several studies have suggested that
it is follicular reserve—and thus how near a woman is
to menopause, rather than chronological age—that is
most important for aneuploidy risk. An increase in
aneuploidy and a shortened reproductive lifespan were
found in mice after surgical removal of an ovary (Brook
et al. 1984). Similarly, it has been found that congenital
absence or surgical removal of an ovary in humans sig-
nificantly increased the risk of having a child with Down
syndrome (odds ratio 9.6) (Freeman et al. 2000). A link
between follicular reserve and aneuploidy is further
suggested by the finding that median age at meno-
pause was earlier among 111 women with trisomic SAs
than among control women (Kline et al. 2000). Al-
though women with premature ovarian failure (POF)
have fewer live births than women with normal men-
opause, the former were more likely to have had three
or more SAs (Chernyshov et al. 2001). Furthermore,
miscarriage rates in women with diminished ovarian
reserve—defined on the basis of levels of follicle stim-
ulating hormone (FSH) on day 3 of the reproductive
cycle—are significantly higher than those of age-
matched controls (Hofmann et al. 2000; Levi et al.
2001) and are at a greater risk of fetal aneuploidy, most
commonly trisomy (Nasseri et al. 1999).
The link between trisomy risk and follicular atresia
leads us to suggest that skewed XCI in the women from
the present study reflects a mechanism leading to fewer
follicles at birth or to accelerated follicular atresia. It is
possible that poor early growth could affect the oocyte
pool. Earlier menopause has been associated with poor
growth late in gestation (Cresswell et al. 1997). Fur-
thermore, mice that survived treatment with a growth
inhibitor during embryogenesis had a severe reduction
in germ cell populations, accompanied by reduced fer-
tility (Tam and Snow 1981). Any event that causes a
reduction of size of the pool of embryonic precursors
may not only affect the oocyte pool but would also be
expected to lead to an increased risk of skewed XCI
because of stochastic factors (Robinson et al. 2001a).
Increased follicular atresia can be caused by X-linked
factors, as demonstrated by POF in women with X-
autosome translocations, X-linked deletions, mono-
somy X, and certain mutations of X-linked genes (Simp-
son and Rajkovic 1999; Mumm et al. 2001). Although
large rearrangements may lead to POF, it is possible
that subtle changes may lead to less severe follicular
depletion, which then manifests as a higher risk of tri-
somy at a slightly earlier age. X-linked deletions, trans-
locations, and mutations are also frequent causes of
skewed XCI. An increased rate of oocyte atresia has
also been observed in female infants affected with
monosomy X and trisomies 13, 18, or 21 (reviewed by
Cunniff et al. [1991] and Ogata and Matsuo [1995]).
Therefore, germline trisomy mosaicism in phenotypi-
cally normal individuals could also cause reduced ovar-
ian reserve. Although germline trisomymosaicism could
contribute directly to trisomic pregnancies through the
production of aneuploid oocytes, this has not been doc-
umented for trisomies other than 18 and 21 (Robinson
et al. 2001b). We suggest that it is more likely that
germline trisomy mosaicism leads to increased trisomy
risk through reduced ovarian reserve. Germline trisomy
mosaicism has been reported in association with mo-
saicism confined to the placenta (Stavropoulos et al.
1998), which, in turn, has been associated with skewed
XCI (Lau et al. 1997; Pen˜aherrera et al. 2000).
There is no doubt that X-linked mutations can be
associated with skewed XCI and an increased rate of
SA in families (Pegoraro et al. 1997; Lanasa et al. 2001).
Do male lethal X-linked mutations occur often enough
to significantly contribute to the etiology of RSA? An
increase in female live births in patients with skewed
XCI, compared with the expected 1:1 ratio, has been
observed, suggesting that male-lethal X-linked muta-
tions could be a cause of loss of pregnancy among
women with skewed XCI and RSA (Lanasa et al. 2001),
although the losses were not karyotyped to corroborate
this possibility. In contrast, the present study does not
show an increase in SAs of male conceptuses or in fe-
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male live births. Thus, male-lethal X-linked mutations
are an unlikely explanation for the losses experienced
by the majority of women with skewed XCI and RSA.
There are few proven causes of trisomy. The finding
of increased occurrence of skewed XCI among women
who have experienced a trisomic pregnancy thus pro-
vides a clue to its etiology and suggests that reduced
size of the pool of embryonic precursors and reduced
ovarian reserve could lead to increased susceptibility to
chromosomally abnormal pregnancies. However, it will
be important to conduct additional studies to confirm
this possible association. In particular, theremay be only
a subset of trisomies to which these findings apply. Since
the main underlying cause of the association between
skewed XCI and trisomy is not yet known, skewed X
CI is not currently recommended as a diagnostic tool.
Nonetheless, with further research, skewed XCI could
perhaps be used as an early indicator of an increased
risk of trisomy and could allow women to plan their
families with greater knowledge of their own specific
age-related risk of aneuploidy or loss.
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